Targeted scan detects hidden multiple myeloma missed by standard imaging
A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy. The phase 2 clinical trial was led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Drawings of near-death experiences reveal patterns in what people remember seeing
United Kingdom
-
Kudzu supplement helps people cut back on binge drinking
United Kingdom
-
Cannabis dominates youth hospital visits while alcohol impacts older adults
United Kingdom
-
Lung antibodies can be measured in exhaled breath
United Kingdom
-
Moderate drinking carries health risks even within UK alcohol guidelines
United Kingdom
-
New workflow tracks lipid changes in oil-producing yeast species
United Kingdom
-
Digital therapy offers new way to prevent worsening anxiety around childbirth
United Kingdom
-
Student-run Automotive Shop Opens to the Public in Houston Where Every Oil Change Helps the Next Generation
United Kingdom